Area of research
Otorhinolaryngology · Molecular Biology
Research interest
Research interests include Head and Neck Cancer Studies, Cervical Cancer and HPV Research, RNA Research and Splicing, and Cancer Genomics and Diagnostics.
Oral human papillomavirus (HPV) prevalence and genotyping among healthy adult populations in the United States and Europe: results from the PROGRESS (PRevalence of Oral hpv infection, a Global aSSessment) study
Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization study
Human papillomavirus‐driven head and neck cancers in Japan during 2008–2009 and 2018–2019: The BROADEN study
Development and external validation of a head and neck cancer risk prediction model
Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis
Oral Human Papillomavirus Prevalence and Genotyping Among a Healthy Adult Population in the US
A risk prediction model for head and neck cancers incorporating lifestyle factors, <scp>HPV</scp> serology and genetic markers
Accuracy of high-risk HPV DNA PCR, p16(INK4a) immunohistochemistry or the combination of both to diagnose HPV-driven oropharyngeal cancer
Concordance of p16INK4a and E6*I mRNA among HPV-DNA-Positive Oropharyngeal, Laryngeal, and Oral Cavity Carcinomas from the ICO International Study
The BROADEN study: The design of an observational study to assess the absolute burden of HPV-related head and neck cancers
Oral human papillomavirus (HPV) and associated factors among healthy populations: The design of the PROGRESS (PRevalence of Oral hpv infection, a Global aSSessment) study
Association of antiretroviral therapy with anal high-risk human papillomavirus, anal intraepithelial neoplasia, and anal cancer in people living with HIV: a systematic review and meta-analysis
Role of Human Papillomavirus Infection in Head and Neck Cancer in Italy: The HPV-AHEAD Study
Absence of disruptive <i>TP53</i> mutations in high‐risk human papillomavirus‐driven neck squamous cell carcinoma of unknown primary
Double positivity for HPV-DNA/p16ink4a is the biomarker with strongest diagnostic accuracy and prognostic value for human papillomavirus related oropharyngeal cancer patients
Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: A retrospective multicentre study
HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients
Evidence of the causal role of human papillomavirus type 58 in an oropharyngeal carcinoma